InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool
InMode introduces Morpheus8 Cool with integrated surface cooling and guided presets to enhance comfort and control in RF microneedling procedures.
Rhea-AI Summary
InMode (INMD) launched Morpheus8 Cool, an enhanced RF microneedling solution available exclusively on the new Morpheus8MAX platform.
Morpheus8 Cool introduces a redesigned handpiece and large-surface cooling tip with Cool Comfort Technology to manage the thermal profile during treatment and improve patient comfort. The system also adds an interactive user interface that supports two options: Guided Mode, offering preset, clinically effective parameters for consistent, repeatable outcomes, and Manual Mode for fully customizable settings. Company clinicians state that surface cooling maintains tissue remodeling effects while elevating the treatment experience.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Recognized as the world's #1 RF microneedling procedure, Morpheus8 is establishing a new industry standard with Morpheus8 Cool. The new handpiece and large-surface cooling tip feature game-changing Cool Comfort Technology, intelligently managing the thermal profile to elevate the treatment experience. Morpheus8 Cool also features a new interactive user interface for enhanced control and safety. Practitioners can select Guided Mode, with preset, clinically effective parameters that support consistent, repeatable outcomes, or Manual Mode for fully customizable settings.
"Developed in response to feedback from our providers, Guided Mode within the Morpheus8MAX platform offers greater versatility across their practices," said Dr. Michael Kreindel, InMode Chief Technology Officer and co-founder. "Its intuitive design gives practitioners greater flexibility to tailor treatments to each patient's skin concerns and anatomy while delivering the remarkable results patients and providers have come to expect from Morpheus8."
"Morpheus8 Cool addresses an important challenge in aesthetics: how to make a proven, successful technology even better," said Dr. Eran Krieger, Chief Medical Officer at InMode. "By cooling the skin's surface while treating the targeted tissue, we preserve the remodeling effect without compromising treatment. We are not changing the treatment—we are elevating the patient experience."
"The excitement surrounding Morpheus8 Cool was undeniable when we introduced it at our Insider Summit in
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Press Contact:
Behrman Cesa Communications
inmode@behrmancesa.com
Investor Contact:
MS-IR LLC
Miri Segal – Scharia
ir@inmodemd.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-advances-rf-microneedling-comfort-with-the-launch-of-morpheus8-cool-302872766.html
SOURCE InMode Ltd.
FAQ
What is Morpheus8 Cool and how does it differ from existing Morpheus8 treatments?
Morpheus8 Cool is described as the next evolution of InMode’s Morpheus8 RF microneedling technology, offered only on the Morpheus8MAX platform. It adds a new handpiece and large-surface cooling tip with Cool Comfort Technology that manages the thermal profile to improve comfort while maintaining the targeted tissue remodeling effect.
What treatment modes does the Morpheus8 Cool system offer practitioners?
The Morpheus8 Cool handpiece runs on the Morpheus8MAX platform and offers two main modes: Guided Mode, which uses preset, clinically effective parameters designed to support consistent, repeatable outcomes, and Manual Mode, which allows fully customizable treatment settings.
How does InMode describe the benefits of the new cooling feature for patients?
InMode’s Chief Medical Officer states that by cooling the skin’s surface while treating the targeted tissue, Morpheus8 Cool preserves the remodeling effect without compromising the treatment, with the goal of elevating the overall patient experience and comfort.
What feedback did providers give when Morpheus8 Cool was first introduced?
InMode reports that when Morpheus8 Cool was introduced at its Insider Summit in Las Vegas, providers responded enthusiastically and “immediately recognized the value” of greater comfort, precision, and control, which the company views as reinforcing demand for this evolution of Morpheus8 technology.
In which medical fields does InMode currently market its RF-based technologies?
InMode develops, manufactures, and markets RF-based devices for multiple specialties, including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology, and offers a comprehensive line of minimally invasive RF products across these categories.